This study looks at how diabetes affects the eyes, especially the retina, over time. The retina is the part of the eye that helps us see. People with a condition called Diabetic Macular Edema (DME) are treated with special medicines called Anti-VEGF Agents. VEGF stands for Vascular Endothelial Growth Factor, a protein that can cause blood vessels to grow too much and leak in the eye. The study aims to find better ways to measure and understand changes in the eye due to diabetes. This could help develop new treatments.
Key Points:
- Length of Study: The study requires long-term participation to observe changes over time.
- Eligibility: Participants must be 18 or older with Type 1 or Type 2 diabetes and have good vision in at least one eye.
- Exclusions: Certain eye conditions or recent surgeries may disqualify participation.
How understandable was the trial content above?
Hard to understand
Easy to understand